Positive Results Of Bharat Biotech COVID-19 Vaccine “COVAXIN” In US
Hyderabad: Positive results have been seen in two and three-phase clinical trials conducted in America on Bharat Biotech's Covid-19 vaccine Covaxin".
Browsing Tag
covaxin
Covaxin safe for children between 2-18 years
Bharat Biotech today announced that BBV152 (Covaxin), its whole-virion inactivated Covid-19 vaccine candidate, has proven to be safe, well-tolerated, and immunogenic in paediatric subjects in phase II/III study.
Bharat Biotech had…
Covaxin for children aged 12 and above approved
The Drug Controller General of India (DCGI) on Saturday approved Covaxin for emergency use for children above 12 years. The approval is for children between 12 to 18 years of age only. The vaccine is not for children below 12 years.
…
Indian Expert Panel Recommends Emergency Use Approval for Covaxin in 2 to 18 Age Group
An expert panel of India's Central Drug Authority has recommended granting emergency use authorisation to Bharat Biotech's Covaxin for children in the 2 to 18 years age group with certain conditions, sources said on Tuesday.
No Newborn Calf Serum in Covaxin: Government
The Union Ministry of Health and Family Welfare on Wednesday clarified that the Bharat Biotech's Covaxin does not contain newborn calf serum.